ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2053

Global Mirna Expression and Transcriptomic Profiling of Monocytes from RA Patients

Marzena Ciechomska1, Krzysztof Bonek2, Piotr Gluszko2, Marzena Olesinska2, Bartosz Wojtas3, Vladimir Benes4 and Wlodzimierz Maslinski1, 1Department of Pathophysiology and Immunology, National Institute of Geriatrics Rheumatology and Rehabilitation, Warsaw, Poland, Warsaw, Poland, 2Department of Rheumatology, National Institute of Geriatrics Rheumatology and Rehabilitation, Warsaw, Poland, Warsaw, Poland, 3Nencki Institute of Experimental Biology, Warsaw, Poland, Warsaw, Poland, 4The European Molecular Biology Laboratory, Heidelberg, Germany, Heidelberg, Germany

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Epigenetics, MicroRNA, monocytes and rheumatoid arthritis, pathogenesis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Rheumatoid Arthritis – Etiology and Pathogenesis Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Infiltration of the synovium by mononuclear cells, including monocytes, is one of the main features of RA. Monocytes are the first immune cells which migrate from blood to the site of inflammation leading to tissue destruction due to enhanced proinflammatory cytokines secretion and overall RA development. It has been shown that abnormalities in miRNA expression are related to inflammatory molecules production by mononuclear cells, however miRNAs have never been fully analysed in monocytes population. The aim of this study was to explore global miRNA and transcriptomic profiling of monocytes from RA patients to predict which aberrantly expressed miRNA can negatively modulate inflammatory molecules.

Methods: Total RNAs from CD14+ monocytes of 12 RA and 10 healthy control (HC) were isolated. The samples were barcoded using Small-RNA-Library-Set for miRNA and simultaneously for RNA-Seq transcriptomic profiling using Illumina HiSeq 2000 platform. Hierarchical clustering was performed to select upregulated miRNAs and significantly downregulated transcripts which are predicted to be the putative target gene of miRNAs. Following computational analysis, selected miRNAs-mRNA candidates were validated using qPCR. Finally, the miRNA candidate was correlated (using Spearman analysis) with clinical parameters including DAS28.

Results: Using next generation sequencing (NGS), we received 10 million reads from each sample. Following computational analysis, we selected 14 specific miRNA candidates which are predicted to target inflammatory mediators out of 188 significantly changed miRNAs in RA monocytes vs HC. Based on the highest scoring in terms of negative correlation (r= -0.97, p=1.7e-07, FDR=0.04) and the number of seed regions of miRNA (n=5) binding with the 3’UTR of mRNA, we selected miRNA-146b-3p and its target gene anti-inflammatory retinoic acid receptor alpha (RARA) transcript. In addition, miRNA-146b-3p was 1.12-fold upregulated (p=0.02) compared to HC monocytes. Similarly to NGS studies, qPCR analysis confirmed significantly increased expression of miRNA-146b-3p in RA vs HC monocytes (3.2-fold, p=0.01) and negative correlation between miRNA-146b-3p and RARA expression (r= -0.39, p=0.031). In addition, both NGS and qPCR analyses demonstrated negative correlation between miRNA-146b-3p expression and DAS28 score (r= -0.75, p=0.009 and r= -0.62, p=0.034, respectively).

Conclusion: We have identified a new miRNA candidate miRNA-146b-3p which is predicated to negatively regulate anti-inflammatory RARA transcript that may elucidate an increased inflammatory phenotype of RA monocytes.

Supported by 2015/16/S/NZ6/00041 from National Science Centre, Poland and EMBO ST Fellowship


Disclosure: M. Ciechomska, None; K. Bonek, None; P. Gluszko, None; M. Olesinska, None; B. Wojtas, None; V. Benes, None; W. Maslinski, None.

To cite this abstract in AMA style:

Ciechomska M, Bonek K, Gluszko P, Olesinska M, Wojtas B, Benes V, Maslinski W. Global Mirna Expression and Transcriptomic Profiling of Monocytes from RA Patients [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/global-mirna-expression-and-transcriptomic-profiling-of-monocytes-from-ra-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/global-mirna-expression-and-transcriptomic-profiling-of-monocytes-from-ra-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology